Health

8 Questions to Ask Your Doctor Before Starting Treatment for Moderate to Severe Atopic Dermatitis

8 Questions to Ask Your Doctor Before Starting Treatment for Moderate to Severe Atopic Dermatitis
Image: health.yahoo.com

Regular moisturizing, gentle skin care, and topical medications are typically the starting point for managing atopic dermatitis (AD), the most common form of eczema. But in moderate to severe cases, your dermatologist may recommend a different approach.

That's where systemic medications, which work throughout the body, come into the picture: Options include biologics, oral JAK (Janus kinase) inhibitors, and immunosuppressants such as cyclosporine (Neoral, Sandimmune) and methotrexate (Otrexup, Rasuvo, Trexal).

But before proceeding, you may want to know the ins and outs of your new treatment. Here's what to ask your dermatologist before starting a medication for moderate to severe AD.
1. Why Are You Recommending This Treatment for Me?
Many factors are involved in deciding which treatment is best suited to you, according to Steven Daveluy, MD, a professor and the program director of the dermatology residency program at Wayne State University's School of Medicine in Detroit, where he specializes in treating people with skin conditions like psoriasis and eczema.

Your symptoms, previous treatments, and how AD affects your life help determine which treatment to choose, he says. Your personal and family medical histories matter, too.

"A patient's health history is a critical part of the decision for any medication. Two people can have equally troublesome eczema but be very different candidates for the same medication," Dr. Daveluy says. "I consider the patient's age, how active their eczema is, what treatments they've already tried, and whether those treatments worked or caused side effects. I also ask how much the disease affects their sleep and daily life and what they hope to achieve with treatment."

Pregnancy plans, breastfeeding, and vaccination status are also important considerations, he says.
2. What Improvements Should I Expect, and How Soon?
"Will this work?" and "How soon will I see results?" are among the most common questions Daveluy's patients ask him.

It's understandable - you want to set realistic expectations. "Patients with moderate to severe eczema may have spent years trying different treatments, dealing with unpredictable flares, and losing sleep because of itching. They want to know whether the next treatment will finally give them meaningful relief," Daveluy says.

In some people, symptoms may take weeks to months to settle, says Dawn Davis, MD, a professor of dermatology and pediatrics at Mayo Clinic in Rochester, Minnesota, and a cochair of the American Academy of Dermatology guidelines committee on AD.

"I like to remind patients that their disease did not come on overnight. It's going to take time for the immune system cascade to calm and for the damage and inflammation that's in the skin currently to subside," Dr. Davis says.

Ask when you should book a follow-up to assess your response and whether you'll need laboratory monitoring.
3. Should I Be Worried About the Black Box Warning?
Side effects and potential risks may be front-of-mind if you're prescribed a medication with a so-called black box warning. Oral JAK inhibitors, for example, carry warnings about infections, cancer, serious cardiovascular events, blood clots, and death.

Concerns stem from a study of oral tofacitinib (Xeljanz) in people with rheumatoid arthritis (RA) who were at least 50 years old and had at least one cardiovascular risk factor. The U.S. Food and Drug Administration (FDA) updated warnings for tofacitinib and other oral JAK inhibitors because they work in similar ways.

Discuss any concerns with your dermatologist, says Peter Lio, MD, a clinical assistant professor of dermatology and pediatrics at Northwestern University's Feinberg School of Medicine in Chicago. "The goal is not to dismiss the warnings, but to interpret them thoughtfully and put them into context," he says.

Dr. Lio says your dermatologist can explain how the risks outlined in the warning apply to you according to your age, smoking history, cardiovascular risk factors, and other medical conditions, then weigh those risks against the potential benefits of treatment.
4. What Side Effects Should I Watch Out For?
Ask about the common side effects of your prescribed medication and how to manage them. They'll vary by treatment, Davis says.

Common side effects of oral JAK inhibitors include acne, nausea, and headache. "We also discuss the possibility of infections, including shingles and other viral infections," Daveluy says.

If you're using topical medications as well, some can cause burning, stinging, or irritation when applied to inflamed skin, Davis says.

Certain biologic medications, including dupilumab (Dupixent), can cause conjunctivitis, aka pink eye.

Before starting treatment, make sure you know which symptoms warrant a call to your dermatologist and which require immediate medical attention. Chest discomfort, shortness of breath, or coughing up blood require emergency evaluation, Davis says. Tell the emergency department team which medications you're taking, including any JAK inhibitors or biologics. While side effects like these aren't common, it's important to know what to watch out for.
5. How Will This Treatment Fit Into My Daily Routine?
How you take medication and how often you need it matters. Discuss your preferences about pills versus injections and any practical concerns about managing treatment along with your work and home life.

In a commentary piece, Lio and his coauthor proposed evaluating treatments across five areas: efficacy, safety, tolerability, accessibility, and the potential to achieve remission.

It's not just about which drug yields the best results in clinical trials, Lio says.

"A medication might be extraordinarily effective but require frequent laboratory monitoring, cause bothersome side effects, or be difficult to obtain through insurance," Lio says. "Another treatment might work a little more slowly but offer a more convenient dosing schedule or the possibility of maintaining control with less-frequent treatment."

Get instructions about whether your medication should be taken with food, how to store it, and what to do if you miss a dose, Daveluy says.
6. How Much Will It Cost, and What if Insurance Doesn't Cover It?
Checking your insurance coverage before your appointment may help avoid delays. You should ask your insurance provider which therapies are covered specifically for AD, Davis says.

"Sometimes patients will be proactive, and they'll ask what drugs are covered but they won't understand that the insurance company covers them only for a particular set of diseases," she says.

Check your share of medication, laboratory, and follow-up appointment costs, Daveluy says.

"Cost is an important part of treatment, and patients should never feel uncomfortable bringing it up. The most effective treatment on paper isn't helpful if a patient cannot afford to take it," Daveluy says.

Some insurers require prior approval or what's called step therapy, which means you have to try certain lower-cost treatments and have them fail before the more expensive option your doctor prescribed is covered. If coverage is denied, your dermatologist's office can help you appeal the decision or connect you to financial assistance programs, Daveluy says.
7. What Should I Do if My Skin Clears Up - or I Still Have Flares?
When your skin condition improves, you'll want to know how to maintain your results.

Don't reduce or stop treatment without consulting your doctor. "Just because the skin looks clear doesn't necessarily mean the disease has disappeared," Lio says.

Maintenance therapy, gentle skin care, and a plan for flares are also important, he says.

In the case of flares, Davis prescribes topical steroids or calcineurin inhibitors that people can use alongside their ongoing treatment.
8. How Can I Advocate for Myself and Explore Other Options?
Advocating for yourself means understanding your personal situation and asking for help navigating your options, Davis says.

Come prepared to discuss your past and current medical conditions, along with your family medical history, which can guide your dermatologist in choosing treatments that are appropriate for your overall health. "I can't really answer the question of what systemic therapy a patient should have until I know that information," Davis says.

Davis recommends asking whether phototherapy (aka ultraviolet light therapy) could be an alternative to systemic medication, and whether patch testing might help identify a contact allergy that may be triggering flares.

You can also ask where to find reliable information and support. Davis recommends the American Academy of Dermatology Association's AD guidelines and the National Eczema Association's educational resources for people with AD and caregivers.
The Takeaway
The right treatment for moderate to severe atopic dermatitis depends on more than clearing your skin: Safety, tolerability, affordability, and how well treatment fits your goals and daily routine all matter, too.

Ask your dermatologist when to expect results, which side effects to watch for, and how dosing and storage requirements will fit alongside work, caregiving, and travel.

Take a proactive approach to treatment discussions by knowing your personal and family medical history and checking which medications your insurance covers specifically for atopic dermatitis.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.

Resources

Atopic Dermatitis: Updated Guidelines From the AAAAI/ACAAI Joint Task Force on Practice Parameters. American Family Physician. October 2024.

FDA Requires Warnings About Increased Risk of Serious Heart-Related Events, Cancer, Blood Clots, and Death for JAK Inhibitors That Treat Certain Chronic Inflammatory Conditions. U.S. Food and Drug Administration. December 7, 2021.

Ytterberg S R et al. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. New England Journal of Medicine. January 26, 2022.

Yancey JR et al. Effectiveness of Topical Anti-Inflammatory Drugs for Eczema. American Family Physician. July 2025.

An M et al. Reaching for the Stars in Atopic Dermatitis: Efficacy, Safety, Tolerability, Accessibility, and Remission/Remittive Effects (ESTAR). Journal of Clinical and Aesthetic Dermatology. November 2025.
Meet Our Experts
See Our Editorial Policy Meet Our Health Expert Network

Susan-Bard-bio
Susan Bard, MDMedical Reviewer
Castle Connolly Top Doctor

Susan Bard, MD, is a clinical instructor in the department of dermatology at Weill Cornell Medicine and an adjunct clinical instructor in the department of dermatology at Mount Sin...

See full bio

carmen-chai-bio
Carmen Chai-OakleyAuthor
Carmen Chai-Oakley is a Canadian journalist and award-winning health reporter. Her interests include emerging medical research, exercise, nutrition, mental health, and maternal and...

See full bio

See Our Editorial Policy Meet Our Health Expert Network

Source: health.yahoo.com